Strategy for Cardiovascular Disease Prevention Through Tailored Health Management in Individuals With Elevated Risk

Launched by CHINA NATIONAL CENTER FOR CARDIOVASCULAR DISEASES · Dec 7, 2022

Keywords

ClinConnect Summary

In this study, investigators aim to develop a series of intervention strategies for cardiovascular disease (CVD) prevention through village doctor-led tailored health management in individuals with elevated risk, then assess their effectiveness through a cluster randomized trial. Investigators hypothesize that the village doctor-led tailored health management can reduce the CVD risk and improve risk factor control of the high-risk subjects through 12 months of follow-up. Around 4200 subjects from 120 villages in mainland China who are considered to be eligible according to inclusion and exc...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 35 or above;
• • High CVD risk which defined as 10-year ASCVD risk ≥10% based on China-PAR prediction model;
• • Ownership of a smart phone and being able to use apps;
• • Being contracted with the local family doctor (village doctor);
• • Willing to participate and able to sign informed consent.
• Exclusion Criteria:
• • CVD history, including myocardial infarction (MI), stroke, heart failure, severe arrhythmia, or peripheral artery disease, or having received percutaneous coronary intervention (PCI) or coronary artery by-pass grafting operation (CABG);
• • Severe illnesses, such as cancer, or severe hepatic and renal dysfunction;
• • Women during pregnancy, lactation, or plan to have children in the next year;
• • Having problems in cognition or communication, or limited daily activities.

Trial Officials